company background image
600285 logo

Henan Lingrui Pharmaceutical SHSE:600285 Stock Report

Last Price

CN¥22.81

Market Cap

CN¥12.8b

7D

-3.3%

1Y

36.7%

Updated

09 Sep, 2024

Data

Company Financials +

Henan Lingrui Pharmaceutical Co., Ltd.

SHSE:600285 Stock Report

Market Cap: CN¥12.8b

Henan Lingrui Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Henan Lingrui Pharmaceutical
Historical stock prices
Current Share PriceCN¥22.81
52 Week HighCN¥26.89
52 Week LowCN¥15.41
Beta0.32
11 Month Change-1.38%
3 Month Change-10.48%
1 Year Change36.67%
33 Year Change108.31%
5 Year Change153.73%
Change since IPO626.80%

Recent News & Updates

If EPS Growth Is Important To You, Henan Lingrui Pharmaceutical (SHSE:600285) Presents An Opportunity

Aug 07
If EPS Growth Is Important To You, Henan Lingrui Pharmaceutical (SHSE:600285) Presents An Opportunity

A Look At The Fair Value Of Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285)

Jul 03
A Look At The Fair Value Of Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285)

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

May 07
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Recent updates

If EPS Growth Is Important To You, Henan Lingrui Pharmaceutical (SHSE:600285) Presents An Opportunity

Aug 07
If EPS Growth Is Important To You, Henan Lingrui Pharmaceutical (SHSE:600285) Presents An Opportunity

A Look At The Fair Value Of Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285)

Jul 03
A Look At The Fair Value Of Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285)

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

May 07
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

May 02
Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Mar 04
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Feb 29
Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Shareholder Returns

600285CN PharmaceuticalsCN Market
7D-3.3%-0.6%-1.4%
1Y36.7%-13.4%-21.4%

Return vs Industry: 600285 exceeded the CN Pharmaceuticals industry which returned -10.7% over the past year.

Return vs Market: 600285 exceeded the CN Market which returned -20.1% over the past year.

Price Volatility

Is 600285's price volatile compared to industry and market?
600285 volatility
600285 Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement5.4%
10% most volatile stocks in CN Market8.6%
10% least volatile stocks in CN Market3.6%

Stable Share Price: 600285 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600285's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19922,530Wei Xiongwww.lingrui.com

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others.

Henan Lingrui Pharmaceutical Co., Ltd. Fundamentals Summary

How do Henan Lingrui Pharmaceutical's earnings and revenue compare to its market cap?
600285 fundamental statistics
Market capCN¥12.85b
Earnings (TTM)CN¥664.16m
Revenue (TTM)CN¥3.52b

19.3x

P/E Ratio

3.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600285 income statement (TTM)
RevenueCN¥3.52b
Cost of RevenueCN¥925.65m
Gross ProfitCN¥2.59b
Other ExpensesCN¥1.93b
EarningsCN¥664.16m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.18
Gross Margin73.68%
Net Profit Margin18.89%
Debt/Equity Ratio2.8%

How did 600285 perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

68%

Payout Ratio